The veterinary diagnostics denotes to the
tests that support in distinguishing and determining the numerous diseases in
the animals. These tests are approved out through the several methods that
utilize their feces, blood and tissue samples. The fresh technologies and
methods that have been structured for the human diagnostics are also utilized
broadly in veterinary diagnostics.
Additionally, the effective increase in the
incidence of zoonotic and foodborne diseases is anticipated to fuel the market
over the review period. Furthermore, the positive growth in the companion
animal proprietorship in underdeveloped countries is another factor supporting
the market growth more positively over the coming years.
According to the report analysis, ‘Global Veterinary Diagnostics Market
(2018-2023)’ states that in the global veterinary diagnostics market there
are several key players which are recently functioning more significantly for
leading the highest market growth and registering the handsome value of market
share around the globe in the coming years while increasing the prevalence of
the product, developing the applications of the technologies, spreading the
awareness related to the applications of the services and decreasing the price
of the services includes IDEXX
laboratories, Inc., Zoetis Inc., HESKA Corporation, Biolas Health, Inc.,
Abaxis, Inc., Neogen Corporation, QIAGEN, bioMerieux SA, Thermo Fisher
Scientific, Inc., Virbac, Randox Laboratories Ltd., IDvet and several others.
In addition, the global veterinary diagnostics
market is predicted to reach USD 5,010.11 Mn by 2023, increasing at a compound
annual growth rate (CAGR) of 9.1% from 2018 to 2023. The budding commonness of
zoonotic diseases-which are communicated from animals to humans-plays an
important role in fueling the market. Primary diagnosis and subsequent
treatment can avoid these diseases from spreading.
Based on the technological sector, the
clinical biochemistry sector registered the market, dominating for 32.3% of the
global revenue in 2017. Increasing the usage of the clinical chemistry
analyzers, glucose observing, and blood gas and electrolyte analysis has
fostered the requirement for clinical biochemistry-based diagnostics.
Immunodiagnostics is predicted to be the
fastest increasing technology sector of the market, enlarging at a prosperous
CAGR of 10.1% during reviewed a period 2018-2023. The pervasiveness of
animal-transmitted diseases has augmented considerably, which in turn, has
fueled the need for diagnostic tests that can speedily and competently detect
pathogens. As a result, the requirement for the immunodiagnostics, involving
the enzyme-linked immunosorbent assay (ELISA), immunoassay, and lateral flow
assays, has augmented speedily.
On the basis of end user, the point of care is
predicted to be the fastest increasing sector during the review period. It is
anticipated to register a steady CAGR of 9.4% during the 2018-2023 period. The
improvement of low-cost and portable instruments with progressive functions has
augmented the growth of point of care diagnostics.
Furthermore, the North America controlled the
principal share of the veterinary diagnostics market in 2017, due to increased
consciousness about the destructive effects of zoonotic diseases. Also,
augmented expenditure by pet owners to develop the pet health and augment the
lifespan of pets has fueled the demand in North America, especially in the
cohort animal segment. Obtainability of attractive pet insurance policies has
played a foremost role in fueling the market in regions like the U.S. and
Canada. The Asia-Pacific region is anticipated to parade the uppermost CAGR
(10.9%) during the 2018-2023 period. Considerable growth in farm animal
populace, particularly in China and India, is likely to fuel the market growth
over the review period.
Therefore, in the near years, it is
anticipated that the global veterinary diagnostics market will increase around
the globe more significantly over the coming years.
For more information, click on the
link below:
Contact Us:
Ken Research
Ankur Gupta, Head Marketing &
Communications
+91
9015378249